<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.5-a.3'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//heiko-gaertner.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://heiko-gaertner.com/schlafprobleme-in-deutschland/</loc>
  <lastmod>2026-11-17T07:32:08Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Heiko Gärtner Mentor für austherapierte Krebspatienten</news:name>
    <news:language>de</news:language>
   </news:publication>
   <news:title>Schlafprobleme in Deutschland</news:title>
   <news:publication_date>2026-11-17T07:32:08Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://heiko-gaertner.com/2026/11/17/online-achtsamkeit-krebs-reduct-studie/</loc>
  <lastmod>2026-11-17T05:50:50Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Heiko Gärtner Mentor für austherapierte Krebspatienten</news:name>
    <news:language>de</news:language>
   </news:publication>
   <news:title>Online-Achtsamkeit bei Krebs: Was die REDUCT-Studie wirklich zeigt</news:title>
   <news:publication_date>2026-11-17T07:00:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://heiko-gaertner.com/schlaf-check-fuehrungskraefte/</loc>
  <lastmod>2026-11-16T14:58:57Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Heiko Gärtner Mentor für austherapierte Krebspatienten</news:name>
    <news:language>de</news:language>
   </news:publication>
   <news:title>Der Schlaf-Check für Führungskräfte</news:title>
   <news:publication_date>2026-11-16T14:58:57Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://heiko-gaertner.com/2026/11/16/durvalumab-enfortumab-vedotin-volga-blasenkrebs/</loc>
  <lastmod>2026-11-16T06:36:53Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Heiko Gärtner Mentor für austherapierte Krebspatienten</news:name>
    <news:language>de</news:language>
   </news:publication>
   <news:title>Durvalumab plus Enfortumab Vedotin vor Blasen-OP: Was VOLGA wirklich zeigt</news:title>
   <news:publication_date>2026-11-16T07:00:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
